Aide Health launches the first AI note-taker for patients

A mission to make prescribed care as effective as possible

We are a design-led health technology company, working to help patients self-manage their conditions and improve the relationship they have with healthcare systems.

Our values

Patient-centred

Our duty of care, above everything else, is to the people who are living with chronic conditions and using our products to manage their health. Our work is designed to empower them and help them achieve better outcomes. We design for the patient first, clinicians a close second.

Long-term view

We are not interested in short-termism. No shortcuts, no quick wins. Using our products means inviting a new technology into your life. That relationship, and the validity of the insights for patients and clinicians, is built on enduring trust. We don’t take this role for granted.

Evidence-based, not evidence-bound

We want our impact to be demonstrable. That said, digital health is new in the lifetime of medicine, and things move quickly. We are willing to challenge accepted thinking and research and put significant effort into proving or disproving the value of our work.

High standards, high humility

Our goal is to set the absolute highest standards in experience design for digital health. This translates into every interaction of our company, large or small. To achieve that, there is a lot we need to learn, and we don’t assume to already know the right answers.

Our history

2021

Company formed

Work begins on novel conversational AI platform.
2022

£1.2m pre-seed

Round led by Salica Investments with Fuel Ventures and Heartfelt.
2023

NHS accelerator

Aide Health is selected to join the prestigious healthtech accelerator.
2024

First national news coverage

Outcomes from our work with Suffolk Primary Care are published in The iPaper.

Class I UK Medical Device

A significant regulatory milestone for our digital chronic condition platform, Aide.
2025

ABHI US Accelerator

Aide Health joins four trade missions to the US with the ABHI.

Six conditions supported

Aide adds pathways for COPD, chronic kidney disease and obesity.

Our investors

Aide Health is backed by some of the leading UK and European venture capital funds, alongside prominent angel investors in the UK and US.

Work with us

All of our design and technology is developed internally. If you want to create digital health products that define the modern transformation of healthcare, we want to hear from you.
See open roles